MeaningCloud Launches Konplik Health, Spin-off of Its Healthcare and Pharmaceutical AI Business
Konplik: Digital transformation of Healthcare, Pharmaceutical and Life Sciences industries with Artificial Intelligence and Natural Language Processing
MeaningCloud, announced the completion of a spin-off from its Artificial Intelligence (AI) businesses into a new, independent company. The spin-off will allow both product and management teams to drive increased responsiveness to customers’ particular needs and achieve faster growth through focused and fit-for-purpose operating models.
Konplik Health begins operations immediately with the health-related assets from MeaningCloud, including its leading text analytics, deep semantic analysis, AI platform, adaptations specific to the life sciences and relevant clients such as Pfizer. Konplik will be dedicated exclusively to the health care, life sciences, and pharmaceutical sectors.
“We’re happy to provide the market with a health-focused AI solution,” says Jose Gonzalez, CEO of Konplik Health. “Together with our customers, we’re leveraging powerful, adaptive intelligence to create solutions that seamlessly integrate data and technology to automate tasks and enable better decisions.”
Recommended AI News: Crypto.Com Debuts French Version Of App And Exchange
Konplik specializes in Robotic Process Automation and Predictive Analytics that rely on the ability to understand large volumes of textual data. There are many examples from Konplik’s 20-years of history in Natural Language Processing and analytics. This history of delivering hundreds of successful AI projects in over 40 different countries to leading innovators in the market includes:
- Search and evaluation for Drug Discovery expediting development
- Analysis of Electronic Health Records and Patient Voice for triaging and coding
- Real-World Evidence analysis of efficacy and safety for Pharmacovigilance
- Real-time market Intelligence for tendering, shortages, price, and demand forecasting
Innovation is deep in Konplik’s DNA, combined with the growing need for automation and data-driven decision making in the Life Sciences. The journey to provide unparalleled value to clients, employees, shareholders and society as a whole accelerates today.